Lisinopril and Pancreatitis necrotising - a phase IV clinical study of FDA data

Summary:

Pancreatitis necrotising is found among people who take Lisinopril, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Lisinopril and have Pancreatitis necrotising. It is created by eHealthMe based on reports of 311,375 people who have side effects when taking Lisinopril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 10, 2023

311,375 people reported to have side effects when taking Lisinopril.
Among them, 101 people (0.03%) have Pancreatitis necrotising.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 325,399 Lisinopril users for its effectiveness, alternative drugs and more.

What is Pancreatitis necrotising?

Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas) is found to be associated with 735 drugs and 348 conditions by eHealthMe.

Number of Lisinopril and Pancreatitis necrotising reports submitted per year:

Could Lisinopril cause Pancreatitis necrotising?

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and have Pancreatitis necrotising?

Check whether Pancreatitis necrotising is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .

Related studies

How severe was Pancreatitis necrotising and when was it recovered:

Pancreatitis necrotising in Lisinopril

Expand to all the drugs that have ingredients of lisinopril:

Pancreatitis necrotising and drugs with ingredients of lisinopril

Alternative drugs to, pros and cons of Lisinopril:

Lisinopril (325,399 reports)

Common Lisinopril side effects:

Fatigue (feeling of tiredness): 20,962 reports
Diarrhea: 17,320 reports
Drug ineffective: 16,717 reports
Pain: 15,476 reports
Breathing difficulty: 15,475 reports
High blood pressure: 14,865 reports
Dizziness: 14,554 reports

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreatitis necrotising treatments and more:

Pancreatitis necrotising (2,213 reports)

COVID vaccines that are related to Pancreatitis necrotising:

Common drugs associated with Pancreatitis necrotising:

All the drugs that are associated with Pancreatitis necrotising:

Pancreatitis necrotising (735 drugs)

Common conditions associated with Pancreatitis necrotising:

High blood pressure: 219 reports
Type 2 diabetes: 145 reports

All the conditions that are associated with Pancreatitis necrotising:

Pancreatitis necrotising (348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lisinopril (the active ingredients of Lisinopril) and Lisinopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.